Abstract
Introduction
Systemic Lupus Erythematosus (SLE) is a Chronic Multisystem Autoimmune disorder that exhibits a wide spectrum of clinical and immunological abnormalities ranging from localized cutaneous involvement to life-threatening systemic involvement. The heterogeneity of SLE manifestations is due to an interplay of genetic, environmental, and hormonal influences[1]. Onset occurs commonly in women of reproductive age, in the third and fourth decades of life, with a Male: Female ratio of about 1:10. The clinical course of the disease is unpredictable with periods of remission and flares.
Multiple organ involvement is common in SLE including the Skin, Joints, Central Nervous System and Kidneys leading to long-term morbidity and mortality [2]. Moreover, Lupus-specific Skin lesions (e.g., Malar rash and Discoid rash) serve primarily as important diagnostic clue, whereas Lupus nonspecific skin lesions (e.g., alopecia and purpura) are associated with more active disease and thus require more aggressive therapy and disease monitoring [3].
The wide spectrum of clinical manifestations in patients with SLE is partially caused by pathogenic autoantibodies. The autoantibodies may potentially target their corresponding autoantigens in the Cell Nuclei, Cytoplasm, Cell-surface membrane, Serum components, Extracellular matrix substances and miscellaneous molecules [3].
Some of these Autoantibodies such as Anti-dsDNA, Antiribosomal P, Anticardiolipin, and Anti-SSB/La are indeed pathogenic as they bind to surface-expressed cross-reactive antigens. These pathogenic autoantibodies not only directly damage the tissues to promote the release of more nuclear antigens, but derail innate and adaptive immune functions. The vicious cycle caused by these pathogenic autoantibodies sustains the chronic immunological and inflammatory abnormalities in patients with SLE[3]. In this study, the Clinical Spectrum of manifestations and Various Systems involved and Immunological pattern in Systemic Lupus Erythematosus patients is studied.
References
- Mathur R, Deo K, Raheja A. Systemic Lupus Erythematosus in India: A Clinico-Serological Correlation. Cureus 2022;14(6).
- Lee MH, Koh JW, Ng CH, Lim SH, Cho J, Lateef A, et al. A meta-analysis of clinical manifestations in asian systemic lupus erythematous: The effects of ancestry, ethnicity and gender. Semin Arthritis Rheum 2022;52:151932.
- Hsieh SC, Yu CL. Autoantibody profiling in systemic lupus erythematosus. Current Biomarker Findings 2013;3:55-65.
- Ghosh AP, Nag F, Biswas S, Rao R, De A. Clinicopathological and immunological profile of patients with cutaneous manifestations and their relationship with organ involvement in systemic lupus erythematosus attending a tertiary care center of Eastern India. Indian J Dermatol 2020;65(1):22-8.
- Stull C, Sprow G, Werth VP. Cutaneous Involvement in Systemic Lupus Erythematosus: A Review for the Rheumatologist. J Rheumatol Suppl 2023;50(1):27-35.
- Bhatt V, Khadke M, Kakrani A, Garg L, Edara M. A Clinical, Biochemical and Immunological Profile of Systemic Lupus Erythematosus in Adult Patients in a Tertiary Care Centre. JMSCR 2020;8(1):401-8.
- Jagdish GA, Va L, KS H. Clinico-immunological Profile of Systemic Lupus Erythematosus: An Observational Study. J Assoc Physicians India 2022;70(3):11-2.
- Talukdar D, Gogoi AP, Doley D, Marak RR, Kakati S, Pradhan V et al.The clinical and immunological profiles of systemic lupus erythematosus patients from Assam, North-East India. Indian J Rheumatol 2020;15(3):181-6.
- Carbone D, Ruffino JP, Martinez F, Chulibert S, Argento MC, Abdala B. Clinical and Immunological Manifestations in Sle Patients in A Third Level Hospital in Rosario, Argentina. Annals of the Rheumatic Diseases 2022; 81:
- Al-Mughales, Jamil A. Anti-Nuclear Antibodies Patterns in Patients With Systemic Lupus Erythematosus and Their Correlation With Other Diagnostic Immunological Parameters. Immunol 2022;13:850759.
- Yan Q, Liu B, Yang M, Li Q, Wang J, Li T, et al. Duration biased distribution of clinical and immunological phenotypes in active SLE. Immunol 2022;13: 1044184.
- Lu W, Zhong Y, Weng C, Wang Q, Tang M, Liu Z et al. Utility of the ACR-1997, SLICC-2012 and EULAR/ACR-2019 classification criteria for systemic lupus erythematosus: a single-centre retrospective study. Lupus Sci Med 2022;9(1).
- Cooper EE, Pisano CE, Shapiro SC. Cutaneous manifestations of “lupus”: systemic lupus erythematosus and beyond. Int J Rheumatol 2022;
- Maloney KC, Ferguson TS, Stewart HD, Myers AA, De Ceulaer K. Clinical and immunological characteristics of 150 systemic lupus erythematosus patients in Jamaica: a comparative analysis. Lupus. 2017;26(13):1448-56.
- O’Brien JC, Chong BF. Not just skin deep: systemic disease involvement in patients with cutaneous lupus. J Investig Dermatol Symp Proc 2017;18(2):69-74.
Corresponding Author
Dr Nivethini.N
Post Graduate Resident, Department of Internal Medicine, Sri Manakula Vinayagar Medical College and Hospital - Puducherry
DOI: https://dx.doi.org/10.18535/jmscr/v12i08.15
